Renata PLC (DSE:RENATA)
Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
395.40
-3.00 (-0.75%)
At close: Dec 4, 2025

Renata Company Description

Renata PLC manufactures, markets, and distributes pharmaceuticals, animal health medicines, oncology-based, agro-based, poultry, and consumer products in Bangladesh.

The company offers generic products, including amantadine, clindamycin, clindamycin, colchicine, dipyridamole, escitalopram, fludrocortisone acetate, hydrocortisone, prednisolone, propylthiouracil, sertraline hydrochloride, terbinafine, and topiramate tablet and capsules.

It also offers specialty products, such as SHK-024, an antidepressant, and SHK 007, to reduce toxicity in pediatrics.

In addition, it provides animal health products. The company was formerly known as Pfizer Laboratories (Bangladesh) Limited and changed its name to Renata Limited in 1993.

Renata PLC was incorporated in 1972 and is headquartered in Dhaka, Bangladesh.

Renata PLC
Country Bangladesh
Founded 1972
Industry Pharmaceutical Preparations
Employees 8,366
CEO Syed S. Kabir

Contact Details

Address:
Plot No. 1
Dhaka, 1216
Bangladesh
Phone 880 2 800 1450
Website renata-ltd.com

Stock Details

Ticker Symbol RENATA
Exchange Dhaka Stock Exchange
Fiscal Year July - June
Reporting Currency BDT
SIC Code 2834

Key Executives

Name Position
Syed S. Kabir Chief Executive Officer
Mustafa Aolad Chief Financial Officer